Medicare Enrolled
Dr. Jolly Varki, MD
Hematology & Oncology · Miami, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Varki from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Varki?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Varki
Dr. Jolly Varki is a hematology & oncology specialist in Miami, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Varki performed 8,731 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Varki received a total of $30,734 from 86 pharmaceutical and/or device companies across 1362 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Varki is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 27% volume in FL
$30,734 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 46310 | Clear | January 31, 2027 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗8,731
Medicare services
Top 27% in FL for hematology & oncology
Not available
Unique patients (not deduplicated)
$12
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Anti-nausea injection (ondansetron/Zofran) | 3,200 | $0 | $15 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
2,072 | $0 | $10 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
777 | $23 | $91 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
590 | $8 | $34 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
588 | $8 | $18 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
328 | $104 | $411 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
316 | $1 | $10 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
306 | $23 | $90 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
214 | $107 | $416 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
130 | $53 | $205 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
71 | $28 | $108 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
70 | $11 | $45 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
50 | $54 | $206 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
19 | $131 | $543 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
13.4% high complexity
69.1% medium
17.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$30,734
Total received (2018-2024)
Avg $4,391/year across 7 years
Top 20% in FL for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
86
Companies
1,362
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$5,556
2023
$5,468
2022
$4,666
2021
$3,647
2020
$2,832
2019
$4,249
2018
$4,317
Payments by company (2024)
Novartis Pharmaceuticals Corporation
$738
AstraZeneca Pharmaceuticals LP
$666
PFIZER INC.
$628
Astellas Pharma US Inc
$589
Celgene Corporation
$542
Janssen Biotech, Inc.
$420
Daiichi Sankyo Inc.
$274
Bayer Healthcare Pharmaceuticals Inc.
$193
Lilly USA, LLC
$166
E.R. Squibb & Sons, L.L.C.
$164
Merck Sharp & Dohme LLC
$162
BeiGene USA, Inc.
$129
GENZYME CORPORATION
$108
Sumitomo Pharma America, Inc.
$104
ABBVIE INC.
$77
Takeda Pharmaceuticals U.S.A., Inc.
$74
ARRAY BIOPHARMA INC
$60
Regeneron Healthcare Solutions, Inc.
$56
Eisai Inc.
$55
Karyopharm Therapeutics Inc.
$53
EMD Serono, Inc.
$39
Ipsen Biopharmaceuticals, Inc
$39
Kite Pharma, Inc.
$26
pharmaand GmbH
$26
Gilead Sciences, Inc.
$25
Tempus AI, Inc
$24
Amneal Pharmaceuticals LLC
$23
Genmab U.S., Inc.
$21
GlaxoSmithKline, LLC.
$20
Alexion Pharmaceuticals, Inc.
$19
Janssen Pharmaceuticals, Inc
$18
SUN PHARMACEUTICAL INDUSTRIES INC.
$15
Top 3 companies account for 36.6% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$3,218
Novartis Pharmaceuticals Corporation
$3,095
Janssen Biotech, Inc.
$2,780
PFIZER INC.
$2,314
Celgene Corporation
$1,599
Astellas Pharma US Inc
$1,568
E.R. Squibb & Sons, L.L.C.
$1,417
Amgen Inc.
$974
Merck Sharp & Dohme Corporation
$925
Merck Sharp & Dohme LLC
$755
Incyte Corporation
$642
BeiGene USA, Inc.
$523
Seagen Inc.
$522
Exelixis Inc.
$522
Lilly USA, LLC
$479
Rigel Pharmaceuticals, Inc.
$465
Daiichi Sankyo Inc.
$436
EMD Serono, Inc.
$434
Genentech USA, Inc.
$430
Eisai Inc.
$427
Gilead Sciences, Inc.
$396
Bayer HealthCare Pharmaceuticals Inc.
$359
GENZYME CORPORATION
$356
Ipsen Biopharmaceuticals, Inc
$331
Myovant Sciences Inc.
$314
NOVARTIS PHARMACEUTICALS CORPORATION
$276
ARRAY BIOPHARMA INC
$214
Coherus Biosciences Inc.
$207
Karyopharm Therapeutics Inc.
$201
Seattle Genetics, Inc.
$195
Bayer Healthcare Pharmaceuticals Inc.
$193
Sumitomo Pharma America, Inc.
$181
Kite Pharma, Inc.
$178
Takeda Pharmaceuticals U.S.A., Inc.
$172
ABBVIE INC.
$171
Clovis Oncology, Inc.
$168
TOLMAR Pharmaceuticals, Inc.
$166
Janssen Pharmaceuticals, Inc
$152
Regeneron Healthcare Solutions, Inc.
$147
Boehringer Ingelheim Pharmaceuticals, Inc.
$137
MEDIVATION FIELD SOLUTIONS LLC
$136
Epizyme, Inc.,
$134
Tolmar, Inc.
$133
GlaxoSmithKline, LLC.
$131
Mirati Therapeutics, Inc.
$129
Taiho Oncology, Inc.
$125
Array BioPharma Inc.
$122
Mylan Institutional Inc.
$105
Pharmacyclics LLC, An AbbVie Company
$103
Janssen Products, LP
$100
ADC Therapeutics America, Inc.
$93
JAZZ PHARMACEUTICALS INC.
$82
Kyowa Kirin, Inc.
$82
Sun Pharmaceutical Industries Inc.
$75
AVEO Pharmaceuticals, Inc.
$74
EISAI INC.
$72
Spectrum Pharmaceuticals Inc.
$70
Verastem, Inc.
$53
TESARO, Inc.
$53
Organon LLC
$51
Deciphera Pharmaceuticals Inc.
$47
AbbVie, Inc.
$43
AbbVie Inc.
$43
Puma Biotechnology, Inc.
$42
Myriad Genetic Laboratories, Inc.
$42
Pharmacosmos Therapeutics Inc.
$40
Genmab U.S., Inc.
$40
Dova Pharmaceuticals
$38
CTI BioPharma Corp.
$38
Stemline Therapeutics Inc.
$38
PUMA BIOTECHNOLOGY, INC.
$37
Ethicon US, LLC
$35
pharmaand GmbH
$26
TAIHO ONCOLOGY, INC.
$25
MorphoSys, US Inc.
$24
Tempus AI, Inc
$24
SOBI, INC
$23
Amneal Pharmaceuticals LLC
$23
Pharmacyclics LLC, an AbbVie Company
$22
SANOFI-AVENTIS U.S. LLC
$22
Alexion Pharmaceuticals, Inc.
$19
Midatech Pharma US Inc
$18
Jazz Pharmaceuticals Inc.
$17
Boston Scientific Corporation
$16
Teva Pharmaceuticals USA, Inc.
$16
SUN PHARMACEUTICAL INDUSTRIES INC.
$15
Top 3 companies account for 29.6% of all-time payments
Associated products mentioned in payments ›
ABECMA · ADCETRIS · AFINITOR · ALIMTA · AVASTIN · Abraxane · Alecensa · Aliqopa · Aranesp · BAVENCIO · BENDEKA · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · Braftovi · CABOMETYX · CALQUENCE · CARVYKTI · CERTUS 140 MICROWAVE ABLATION SYSTEM · CHANTIX · CYRAMZA · Cabometyx · Copiktra · DARZALEX · Doptelet · ELAHERE · ELIGARD · ELIQUIS · ELITEK · ELREXFIO · EMPLICITI · ENHERTU · ERBITUX · ERLEADA · Enhertu · Epkinly · Erleada · FARESTON · FASLODEX · FOTIVDA · Folotyn · Fulphila · GAZYVA · GILOTRIF · Gelclair · Herceptin · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · IRESSA · Imbruvica · Inrebic · JAKAFI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LENVIMA · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LONSURF · LORBRENA · LUMAKRAS · LUPRON DEPOT · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lupron Depot · MEKINIST · MONJUVI · MONOFERRIC · MVASI · NERLYNX · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · OJJAARA · ONIVYDE · ONTRUZANT · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Odomzo · Ogivri · Onivyde · Orserdu · PADCEV · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · Perjeta · Polivy · Pomalyst · QINLOCK · REBLOZYL · Revlimid · Rezlidhia · Rubraca · SANDOSTATIN · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SPRYCEL · SUTENT · Stivarga · TABRECTA · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TEVIMBRA · TUKYSA · Tavalisse · Tecentriq · TheraSphere Y90 Glass Microspheres 10 GBq · Trodelvy · ULTOMIRIS · Udenyca · VENCLEXTA · VERZENIO · VOTRIENT · Vectibix · Vonjo · Vyloy · XALKORI · XARELTO · XGEVA · XPOVIO · XT CDX · XTANDI · Xofigo · Xospata · Xtandi · YONSA · YONSA (abiraterone acetate) · Yescarta · ZEJULA · ZEPZELCA · ZYTIGA · myRisk
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
179
County median income
$68,694
Nearest hospital to ZIP centroid (approximate)
MIAMI VA MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Varki is a mixed practice specialist, with above-average Medicare volume (top 27% in FL), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Varki experienced with anti-nausea injection (ondansetron/zofran)?
Based on Medicare claims data, Dr. Varki performed 3,200 anti-nausea injection (ondansetron/zofran) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Varki receive payments from pharmaceutical companies?
Yes. Dr. Varki received a total of $30,734 from 86 companies across 1,362 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Varki's costs compare to other hematology & oncology specialists in Miami?
Dr. Varki's average Medicare payment per service is $12. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Varki) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Miami
Browse hematology & oncology specialists in Miami ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in FL
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in FL
Which FL hematology & oncology specialists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology